Loading...
•
Mar 31, 2024
Pacira Q1 2024 Earnings Report
Pacira BioSciences reported financial results for the first quarter of 2024.
Key Takeaways
Pacira BioSciences reported total revenues of $167.1 million for Q1 2024, with net income of $9.0 million, or $0.19 per share. The company also announced a new $150 million share repurchase program.
Total revenues reached $167.1 million.
EXPAREL net product sales were $132.4 million.
Net income was $9.0 million, or $0.19 per share.
A new $150 million share repurchase program was approved.
Revenue by Segment
Forward Guidance
The company is reiterating its full-year 2024 financial guidance.
Positive Outlook
- Total revenue of $680 million to $705 million
- Non-GAAP gross margin of 74% to 76%
- Non-GAAP R&D expense of $70 million to $80 million
- Non-GAAP SG&A expense of $245 million to $265 million
- Stock-based compensation of $50 million to $55 million
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...